Bristol/Accenture Launch Pharmacovigilance Center In India
This article was originally published in PharmAsia News
Executive Summary
Bristol-Myers Squibb and Accenture have established a center for pharmacovigilance as part of Accenture's Life Sciences Centers of Excellence in Chennai, India, Accenture announced Sept. 13
You may also be interested in...
Eisai Teams With Accenture In India For Clinical Data Management
Following the growing trend of outsourcing primary operational functions, Eisai announced Feb. 13 a collaborative effort with Accenture to manage Eisai's Japan, U.S., and European Union clinical data from Accenture's Chennai, India-based delivery center
Eisai Teams With Accenture In India For Clinical Data Management
Following the growing trend of outsourcing primary operational functions, Eisai announced Feb. 13 a collaborative effort with Accenture to manage Eisai's Japan, U.S., and European Union clinical data from Accenture's Chennai, India-based delivery center
Industry Could Help Asia Establish Adverse Event Monitoring Systems – DIA Conference
As countries like India and China reform their pharmacovigilance systems, opportunities are increasing for improved relationships between international companies and regulatory authorities despite stagnant harmonization efforts